Clinical trials of cancer screening in the developing world and their impact on cancer healthcare

Annals of Oncology

Volumn 22, Issue SUPPL.7, 2011, Pages 20-28

  Sankaranarayanan, R ^a   Sauvaget, C ^a   Ramadas, K ^a   Ngoma, T ^a   Teguete, I ^a   Muwonge, R ^a   Naud, P ^a   Nessa, A ^a   Kuhaprema, T ^a   Qiao, Y ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CANCER RESEARCH; CANCER SCREENING; CANCER TEST; CLINICAL TRIAL (TOPIC); CRYOTHERAPY; DEVELOPING COUNTRY; DRUG DOSE COMPARISON; EARLY DIAGNOSIS; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MOUTH CANCER; POINT OF CARE TESTING; PRIORITY JOURNAL; RESOURCE ALLOCATION; UTERINE CERVIX CANCER; ADULT; FEMALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; STANDARD;

ADULT; CLINICAL TRIALS AS TOPIC; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS;

EID: 84855411778     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr422     Document Type: Article

References (73)

1. Viviani S, Carrieri P, Bah E et al. 20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 3216-3223.
2. Sankaranarayanan R, Basu P, Wesley RS et al. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 2004; 110: 907-913.
3. Sankaranarayanan R, Ramadas K, Thomas G et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet 2005; 365: 1927-1933.
4. Sankaranarayanan R, Esmy PO, Rajkumar R et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a clusterrandomised trial. Lancet 2007; 370: 398-406.
5. Sankaranarayanan R, Nene BM, Shastri SS et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-1394.
6. Muwonge R, Mbalawa CG, Keita N et al. Performance of colposcopy in five sub-Saharan African countries. BJOG 2009; 116: 829-837.
7. Muwonge R, Manuel MG, Filipe AP et al. Visual screening for early detection of cervical neoplasia in Angola. Int J Gynaecol Obstet 2010; 111: 68-72.
8. Screening Group. International Agency for Research on Cancer. Available at. http://screening.iarc.fr/.
9. Ferlay J, Shin HR, Bray F et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. 2010. Available from: http://globocan.iarc.fr.
10. Ngoma T, Muwonge R, Mwaiselage J et al. Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania. Int J Gynaecol Obstet 2010; 109: 100-104.
11. Kuhn L, Wang C, Tsai WY et al. Efficacy of human papillomavirus-based screenand-treat for cervical cancer prevention among HIV-infected women. AIDS 2010; 24: 2553-2561.
12. Batra P, Kuhn L, Denny L. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town. S Afr Med J 2010; 100: 39-44.
13. Denny L, Kuhn L, De SM et al. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA 2005; 294: 2173-2181.
14. Denny L, Kuhn L, Pollack A, Wright TC Jr.. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002; 94: 1699-1707.
15. Denny L, Kuhn L, Pollack A et al. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000; 89: 826-833.
16. Denny L, Kuhn L, Risi L et al. Two-stage cervical cancer screening: an alternative for resource-poor settings. Am J Obstet Gynecol 2000; 183: 383-388.
17. Kuhn L, Denny L, Pollack A et al. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000; 92: 818-825.
18. Wright TC Jr., Kuhn L, Denny L. Human papillomavirus detection to screen for cervical cancer. JAMA 2000; 284: 39-40.
19. Megevand E, Denny L, Dehaeck K et al. Acetic acid visualization of the cervix: an alternative to cytologic screening. Obstet Gynecol 1996; 88: 383-386.
20. Gaffikin L, McGrath J, Arbyn M, Blumenthal PD. Avoiding verification bias in screening test evaluation in resource poor settings: a case study from Zimbabwe. Clin Trials 2008; 5: 496-503.
21. Gaffikin L, McGrath JA, Arbyn M, Blumenthal PD. Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis. BMC Med Res Methodol 2007; 7: 36.
22. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Lancet 1999; 353: 869-873.
23. Blumenthal PD, Gaffikin L, Deganus S et al. Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol 2007; 196: 407-408.
24. De Vuyst H, Claeys P, Njiru S et al. Comparison of pap smear, visual inspection with acetic acid, human papillomavirus DNA-PCR testing and cervicography. Int J Gynaecol Obstet 2005; 89: 120-126.
25. Sangwa-Lugoma G, Mahmud S, Nasr SH et al. Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. Int J Cancer 2006; 119: 1389-1395.
26. Mwanahamuntu MH, Sahasrabuddhe V V, Pfaendler KS et al. Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. AIDS 2009; 23: N1-N5.
27. Wesley R, Sankaranarayanan R, Mathew B et al. Evaluation of visual inspection as a screening test for cervical cancer. Br J Cancer 1997; 75: 436-440.
28. Sankaranarayanan R, Wesley R, Somanathan T et al. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer 1998; 83: 2150-2156.
29. Sankaranarayanan R, Shyamalakumary B, Wesley R et al. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. Int J Cancer 1999; 80: 161-163.
30. Basu P, Sankaranarayanan R, Mandal R et al. Evaluation of downstaging in the detection of cervical neoplasia in Kolkata, India. Int J Cancer 2002; 100: 92-96.
31. Basu PS, Sankaranarayanan R, Mandal R et al. Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India. Int J Gynecol Cancer 2003; 13: 626-632.
32. Sankaranarayanan R, Wesley R, Thara S et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer 2003; 106: 404-408.
33. Bhatla N, Gulati A, Mathur SR et al. Evaluation of cervical screening in rural North India. Int J Gynaecol Obstet 2009; 105: 145-149.
34. Pimple S, Muwonge R, Amin G et al. Cytology versus HPV testing for the detection of high-grade cervical lesions in women found positive on visual inspection in Mumbai, India. Int J Gynaecol Obstet 2010; 108: 236-239.
35. Shastri SS, Dinshaw K, Amin G et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ 2005; 83: 186-194.
36. Sankaranarayanan R, Rajkumar R, Esmy PO et al. Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer 2007; 96: 738-743.
37. Nene BM, Hiremath PS, Kane S et al. Effectiveness, safety, and acceptability of cryotherapy by midwives for cervical intraepithelial neoplasia in Maharashtra, India. Int J Gynaecol Obstet 2008; 103: 232-236.
38. Rema P, Suchetha S, Thara S et al. Effectiveness and safety of loop electrosurgical excision procedure in a low-resource setting. Int J Gynaecol Obstet 2008; 103: 105-110.
39. Sankaranarayanan R, Keshkar V, Kothari A et al. Effectiveness and safety of loop electrosurgical excision procedure for cervical neoplasia in rural India. Int J Gynaecol Obstet 2009; 104: 95-99.
40. Sankaranarayanan R, Shastri SS, Basu P et al. The role of low-level magnification in visual inspection with acetic acid for the early detection of cervical neoplasia. Cancer Detect Prev 2004; 28: 345-351.
41. Sankaranarayanan R, Thara S, Sharma A et al. Accuracy of conventional cytology: results from a multicentre screening study in India. J Med Screen 2004; 11: 77-84.
42. Sankaranarayanan R, Rajkumar R, Theresa R et al. Initial results from a randomized trial of cervical visual screening in rural south India. Int J Cancer 2004; 109: 461-467.
43. Sankaranarayanan R, Nene BM, Dinshaw KA et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer 2005; 116: 617-623.
44. Nene B, Jayant K, Arrossi S et al. Determinants of womens participation in cervical cancer screening trial, Maharashtra, India. Bull World Health Organ 2007; 85: 264-272.
45. Sankaranarayanan R, Rajkumar R, Arrossi S et al. Determinants of participation of women in a cervical cancer visual screening trial in rural south India. Cancer Detect Prev 2003; 27: 457-465.
46. Ramadas K, Sankaranarayanan R, Jacob BJ et al. Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India. Oral Oncol 2003; 39: 580-588.
47. Sankaranarayanan R, Mathew B, Jacob BJ et al. Early findings from a communitybased, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer 2000; 88: 664-673.
48. Mathew B, Sankaranarayanan R, Sunilkumar KB et al. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Br J Cancer 1997; 76: 390-394.
49. Pandey M, Thomas G, Somanathan T et al. Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India. Oral Oncol 2001; 37: 103-109.
50. Subramanian S, Sankaranarayanan R, Bapat B et al. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ 2009; 87: 200-206.
51. Ramadas K, Arrossi S, Thara S et al. Which socio-demographic factors are associated with participation in oral cancer screening in the developing world? Results from a population-based screening project in India. Cancer Detect Prev 2008; 32: 109-115.
52. Sankaranarayanan R, Ramadas K, Thara S et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst 2011; 103(19): 1476-1480.
53. Swaminathan R, Selvakumaran R, Esmy PO et al. Cancer pattern and survival in a rural district in South India. Cancer Epidemiol 2009; 33: 325-331.
54. Swaminathan R, Selvakumaran R, Vinodha J et al. Education and cancer incidence in a rural population in south India. Cancer Epidemiol 2009; 33: 89-93.
55. Singh V, Sehgal A, Parashari A et al. Early detection of cervical cancer through acetic acid application-an aided visual inspection. Singapore Med J 2001; 42: 351-354.
56. Parashari A, Singh V, Sehgal A et al. Low-cost technology for screening uterine cervical cancer. Bull World Health Organ 2000; 78: 964-967.
57. Singh V, Sehgal A, Luthra UK. Screening for cervical cancer by direct inspection. BMJ 1992; 304: 534-535.
58. Sehgal A, Singh V, Bhambhani S, Luthra UK. Screening for cervical cancer by direct inspection. Lancet 1991; 338: 282.
59. Mehta FS, Gupta PC, Bhonsle RB et al. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev 1986; 9: 219-225.
60. Amarasinghe HK, Johnson NW, Lalloo R et al. Derivation and validation of a riskfactor model for detection of oral potentially malignant disorders in populations with high prevalence. Br J Cancer 2010; 103: 303-309.
61. Warnakulasuriya KA, Nanayakkara BG. Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka. Cancer Detect Prev 1991; 15: 331-334.
62. Warnakulasuriya KA, Ekanayake AN, Sivayoham S et al. Utilization of primary health care workers for early detection of oral cancer and precancer cases in Sri Lanka. Bull World Health Organ 1984; 62: 243-250.
63. Mittra I, Mishra GA, Singh S et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer 2010; 126: 976-984.
64. Basu P, Nessa A, Majid M et al. Evaluation of the National Cervical Cancer Screening Programme of Bangladesh and the formulation of quality assurance guidelines. J Fam Plann Reprod Health Care 2010; 36: 131-134.
65. Nessa A, Hussain MA, Rahman JN et al. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid. Int J Gynaecol Obstet 2010; 111: 115-118.
66. Deerasamee S, Srivatanakul P, Sriplung H et al. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province. Thailand. Asian Pac J Cancer Prev 2007 8: 547-556.
67. Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project. Lancet 2003; 361: 814-820.
68. Fernandez GL, Sankaranarayanan R, Lence Anta JJ et al. An evaluation of the oral cancer control program in Cuba. Epidemiology 1995; 6: 428-431.
69. Sankaranarayanan R, Fernandez GL, Lence AJ et al. Visual inspection in oral cancer screening in Cuba: a case-control study. Oral Oncol 2002; 38: 131-136.
70. Kujan O, Glenny AM, Oliver RJ et al. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev 2006; 3: CD004150.
71. Kujan O, Glenny AM, Sloan P. Screening for oral cancer. Lancet 2005; 366: 1265-1266.
72. Ramadas K, Arrossi S, Thara S, Sankaranarayanan R. Keynote comment: importance of recognising scientific evidence. Lancet Oncol 2006; 7: 962-963.
73. Oral cancer Screening. National Cancer Institute: U.S. National Institutes of Health. Available at. http://www.cancer.gov/cancertopics/pdq/screening/oral/healthprofessional (29August 2011, date last accessed).